The Traders Daily Report: (OTCBB: SPKL), (OTCBB: SNMB), (OTCBB: ACTC), (OTCBB: QMCI) .
If you enjoy investing in the restaurant sector or if you just enjoy eating good food, then you will want to watch the Spicy Pickle Stockumentary™, located at www.stockwire.com .
----------------------------------------------------------
Chat real-time with other investors about this SPKL news release, by clicking this link: http://www.stockwire.com/SPKL
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=SPKL
Spicy Pickle Franchising Inc. (OTCBB: SPKL)
On Sunday, September 23, 2007, The Stockwire Group released the much anticipated Spicy Pickle Stockumentary to rave reviews.
Spicy Pickle is one of
In short, the company has grown from twenty franchises to nearly one hundred in two short years, with plenty of upside to come. The company is also led by a man named Marc Geman, who is the same CEO who bought the Pretzel Maker franchise and built it from seven stores to 250 and then sold it to Misses Fields Cookies in 1998.
COMPANY NEWS:
Spicy Pickle(R) fast casual restaurants (OTC Bulletin Board: SPKL) today announced the commencement of public trading for its common stock on the Over The Counter Bulletin Board (OTC BB) quotation medium. The company completed its own self underwritten Initial Public Offering, and the stock recently opened for trading.
Empire Financial Group Inc. (http://www.empirefinancialgroup.com) of
Spicy Pickle, a fast casual franchise concept, has been experiencing significant growth. To date there are 26 units open in nine different states. The restaurants differentiate themselves through a culinary-inspired menu of panini, sub sandwiches, Pizzetti Neapolitan thin-crust pizzas, salads, soups and other items, served in a casual neighborhood setting. Spicy Pickle also offers a range of catering and takeout services.
"Spicy Pickle's IPO is an appropriate step at this point in time, given the company's growth curve and success to date," said Marc Geman, President and CEO of Spicy Pickle Inc. "Since our inception in 1999, Spicy Pickle has evolved from a one-store operation in Denver to a chain of restaurants known from coast to coast for its fresh, healthy and innovative approach to lunch and dinner. The capital raised through our public offering will help maintain this unique positioning. We chose to go public at this time to allow investor participation and more efficient access to financing sources as we seek appropriate sources of capital to fuel our growth."
By the end of 2007, Spicy Pickle anticipates opening approximately 14 more units, bringing its network to 40 restaurants in 13 states. Nearly 50 franchise development agreements have also been signed.
In addition to its franchise activity, Spicy Pickle currently has a breakfast menu in test, potentially opening a new daypart for the chain. The company is also in the process of building a major commissary in
To view this incredible Stockumentary™, visit: www.stockwire.com .
About Spicy Pickle Franchising Inc.
Spicy Pickle restaurants serve high quality meats and fine Italian artisan breads, along with a wide choice of ten different cheeses, twenty-one different toppings, and fifteen proprietary spreads to create healthy and delicious panini and sub sandwiches with flavors from around the world. There are over 150,000 delicious sandwich combinations for you to create, along with eight specialty panini sandwiches that have become favorites of our customers. We also boast the world’s best spicy pickle. Spicy Pickle serves the fast growing “fast casual” market where customers demand more than “fast food,” but without the price point of “casual dining”. The hallmark of a Spicy Pickle restaurant is quality, service and an enjoyable atmosphere. Order at the counter, take a seat, enjoy the fun and relaxed atmosphere, and let the staff do what they do best, service.
----------------------------------------------------------
Chat real-time with other investors about this SNMB news release, by clicking this link: http://www.stockwire.com/SNMB
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=SNMB
Sona Mobile Holdings Corp. (OTCBB: SNMB) .
Sona Mobile Holdings Corp. a leading provider of secure gaming software, announced on 9/24/2007 that Lima Uno SAC, owner and operator of one of the largest gaming enterprises in Latin America, has officially launched Sona's server- based gaming system, the Sona Gaming System(TM), at a race and sports book in
----------------------------------------------------------
Chat real-time with other investors about this ACTC news release, by clicking this link: http://www.stockwire.com/ACTC
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=ACTC
Advanced Cell Technology, Inc. (OTCBB: ACTC) .
Advanced Cell Technology, Inc. announced on 9/24/2007 that it has completed the acquisition of all of the outstanding capital stock of Mytogen, Inc. In May 2007, the company announced that it had entered into a letter of intent to acquire Mytogen, Inc. and its Myoblast Program for the treatment of heart failure. A definite merger agreement was signed on July 31, 2007 subject to certain closing conditions. ACTC issued a total of approximately 8.2 million restricted shares of common stock, valued at $5 million and assumed certain Mytogen liabilities. Mytogen shareholders also received a warrant to purchase an additional 1.5 million shares of restricted common stock at $0.75 per share subject to the achievement of certain milestones. Mytogen brings to the company over ten years of experience in clinical trial and FDA experience in developing and advancing cellular therapies including the use of stem cells. This stem cell therapy involves transplantation of expanded autologous myoblasts (adult progenitor stem cells) derived from a small biopsy of skeletal muscle from a patient's leg. The technology allows for the expansion of myoblasts into hundreds of millions of cells over a period of two to three weeks. The resulting myoblasts are then transplanted back into the patient's scarred heart tissue through the use of a catheter-based procedure. The Myoblast Program has successfully completed Phase I human clinical trials using the myoblast platform, utilizing the therapy safely in over 40 patients. Safety of the company's myoblast therapy has been demonstrated in four independent studies. While the Phase I human clinical trials were focused on the safety of the therapy, the clinical data from those trials suggests that the myoblasts often improve function in the heart and may lead to a significant increase in quality of life for the patient. The company applied its myoblast therapy without the use of accompanying arrhythmia preventatives mandated by the FDA for similar programs. The FDA has reviewed the "end-of-Phase I" data and will allow Advanced Cell Technology to proceed with a Phase II human clinical trial. The company plans to begin the Phase II human clinical trial for the treatment of heart failure in approximately 160 patients. If successful, the company expects to proceed with a pivotal Phase III trial. The Myoblast Program may prove particularly beneficial for patients that have experienced a serious heart attack and have a high risk of heart failure. "Advanced Cell Technology has always been on the cutting edge of regenerative medicine and we are excited to join their team," noted Dr. Jonathan Dinsmore, President and Chief Scientific Officer of Mytogen, Inc. "By merging with Advanced Cell, we can now move forward with our clinical trials and bring our therapies to cardiac patients in need of this novel treatment." William M. Caldwell, IV, Chairman and CEO of Advanced Cell Technology remarked, "The completion of this acquisition marks a transformation for our company, as it significantly advances our clinical development activities, placing the company among the most clinically advanced stem cell companies. We now have three distinct programs in various stages of clinical and preclinical development. Our Myoblast Program for the treatment of heart failure will begin Phase II clinical trials shortly, while two of our human embryonic stem cell programs, our Hemangioblast Program for treating blood and cardiovascular disease and our RPE Program for treating retinal degenerative disorders, are in preclinical studies. We expect to file
----------------------------------------------------------
Chat real-time with other investors about this QMCI news release, by clicking this link: http://www.stockwire.com/QMCI
To view in-depth research, click the following link: http://www.stockwire.com/detailed/analysis.php?company=QMCI
QuoteMedia, Inc. (OTCBB: QMCI) .
QuoteMedia, Inc. a leading provider of market data, corporate research information and financial applications, announced 9/24/2007 it has retained market2world communications inc. to assist in the launch of its Quotestream II real-time streaming portfolio management product. market2world is a Web 2.0 product launch and social media agency that specializes in blogger relations (BR) to secure online product previews and reviews from bloggers, podcasters, webcasting and social networking sites on the Internet. "We are committed to building our business and aligning with partners that can take our organization to the next level," said Keith Guelpa, president of QuoteMedia, Inc. "market2world is a top-tiered agency that takes a strategic approach to increasing online visibility. This will be essential for the highly anticipated launch of the Quotestream II product." Market2world communications inc. is a leading Web 2.0 product launch and social media agency providing BR outreach services to capture Long Tail marketing opportunities stemming from the explosion of specialized product-oriented Web sites. According to blog search engine Technorati's latest State of the Live Web report, there are more than 70 million blogs updated at a rate of 17 posts per second or 1.5 million posts per day. "Our role is to actively seek out early adopters and product influencers in the tech and financial blogging communities and social networking sites to generate an online marketing buzz for Quotestream II," said Nathan Rudyk, president of market2world communications inc. "Quotestream II's advanced functionality, its ability to deliver stock quotes and news to more handheld devices than competing products, its low purchase price, and its rapid sign-on for both handheld and desktop versions promises extraordinary adoption by day traders and brokers alike." Prior to founding market2world in 2005, Rudyk has worked for and founded several marcom agencies and led campaigns for Microsoft, EDS, IBM, Nortel and Xerox among many others. He is also an award-winning marketer, author, teacher and broadcaster as well as a blogger and podcaster.
----------------------------------------------------------
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
